Table II.
Modifiable clinical risk factors over follow-up
| Parameter | Year | P-value (first year) | P-value (after first year) | |||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | |||
| N (%) | 324 (100) |
280 (86) |
234 (72) |
167 (52) |
85 (26) |
20 (6) |
||
| Non-HDL-C, mean ± SD [mg/dl] | 143 ±41 |
107 ±33 |
106 ±29 |
105 ±32 |
102 ±31 |
102 ±29 |
< 0.001 | 0.835 |
| LDL-C, mean ± SD [mg/dl] | 118 ±36 |
89 ±28 |
89 ±25 |
88 ±27 |
87 ±26 |
87 ±26 |
< 0.001 | 0.904 |
| HDL-C, mean ± SD [mg/dl] | 53 ±17 |
56 ±18 |
57 ±17 |
58 ±17 |
61 ±17 |
56 ±17 |
0.004 | < 0.001 |
| Triglycerides, mean ± SD [mg/dl] | 128 ±78 |
88 ±49 |
89 ±54 |
83 ±51 |
75 ±46 |
77 ±36 |
< 0.001 | 0.004 |
| Systolic blood pressure, mean ± SD [mm Hg] | 124 ±15 |
118 ±13 |
119 ±13 |
116 ±14 |
114 ±14 |
116 ±13 |
< 0.001 | 0.063 |